Share on StockTwits

Dipexium Pharmaceuticals’ (NASDAQ:DPRX) lock-up period will end on Tuesday, September 9th. Dipexium Pharmaceuticals had issued 2,750,000 shares in its public offering on March 13th, AR Network reports. The total size of the offering was $33,000,000 based on an initial share price of $12.00. After the end of Dipexium Pharmaceuticals’ lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

Dipexium Pharmaceuticals (NASDAQ:DPRX) remained flat at $9.60 during during mid-day trading trading on Thursday. Dipexium Pharmaceuticals has a one year low of $8.00 and a one year high of $15.86. The stock has a 50-day moving average of $9.38 and a 200-day moving average of $9.76. The company’s market cap is $82.0 million.

Dipexium Pharmaceuticals (NASDAQ:DPRX) last issued its quarterly earnings data on Tuesday, August 12th. The company reported ($0.46) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.37) by $0.09. Analysts expect that Dipexium Pharmaceuticals will post $-1.94 EPS for the current fiscal year.

Dipexium Pharmaceuticals, Inc, formerly Dipexium Pharmaceuticals, LLC, is a pharmaceutical company. The Company is focused on the development and commercialization of Locilex.

Receive News & Ratings for Dipexium Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dipexium Pharmaceuticals Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.